Cancer Statistics 2005A Presentation From the American Cancer Society
©2005, American Cancer Society, Inc.
US Mortality, 2002
Source: US Mortality Public Use Data Tape 2002, National Center for Health Statistics, Centers for Disease Control and Prevention, 2004.
1. Heart Diseases 696,947 28.5
2. Cancer 557,271 22.8
3. Cerebrovascular diseases 162,672 6.7
4. Chronic lower respiratory diseases 124,816 5.1
5. Accidents (Unintentional injuries) 106,742 4.4
6. Diabetes mellitus 73,249 3.0
7. Influenza and pneumonia 65,681 2.7
8. Alzheimer disease 58,866 2.4
9. Nephritis 40,974 1.7
10. Septicemia 33,865 1.4
Rank Cause of DeathNo. of deaths
% of all deaths
Change in the US Death Rates* by Cause, 1950 & 2002
* Age-adjusted to 2000 US standard population.Sources: 1950 Mortality Data - CDC/NCHS, NVSS, Mortality Revised.2002 Mortality Data: US Mortality Public Use Data Tape, 2002, NCHS, Centers for Disease Control and Prevention, 2004
22.5
180.7
48.1
586.8
193.9
56.0
193.4
240.1
0
100
200
300
400
500
600
HeartDiseases
CerebrovascularDiseases
Pneumonia/Influenza
Cancer
1950
2002
Rate Per 100,000
2005 Estimated US Cancer Deaths*
ONS=Other nervous system.Source: American Cancer Society, 2005.
Men295,280
Women275,000
27% Lung and bronchus
15% Breast
10% Colon and rectum
6% Ovary
6% Pancreas
4% Leukemia
3% Non-Hodgkin lymphoma
3% Uterine corpus
2% Multiple myeloma
2% Brain/ONS
22% All other sites
Lung and bronchus 31%
Prostate 10%
Colon and rectum 10%
Pancreas 5%
Leukemia 4%
Esophagus 4%
Liver and intrahepatic 3%bile duct
Non-Hodgkin 3% Lymphoma
Urinary bladder 3%
Kidney 3%
All other sites 24%
Cancer Death Rates*, All Sites Combined, All Races, US, 1975-2001
*Age-adjusted to the 2000 US standard population.Source: Surveillance, Epidemiology, and End Results Program, 1975-2001, Division of Cancer Control and Population Sciences, National Cancer Institute, 2004.
0
50
100
150
200
250
300
1975 1977 1979 1981 1983 1985 1987 1989 1991 1993 1995 1997 1999 2001
Men
Both Sexes
Women
Rate Per 100,000
Cancer Death Rates*, for Men, US,1930-2001
*Age-adjusted to the 2000 US standard population.Source: US Mortality Public Use Data Tapes 1960-2001, US Mortality Volumes 1930-1959, National Center for Health Statistics, Centers for Disease Control and Prevention, 2004.
0
20
40
60
80
100
1930 1935 1940 1945 1950 1955 1960 1965 1970 1975 1980 1985 1990 1995 2000
Lung & bronchus
Colon & rectum
Prostate
Pancreas
Stomach
Liver
Rate Per 100,000
Leukemia
Cancer Death Rates*, for Women, US,1930-2001
*Age-adjusted to the 2000 US standard population.Source: US Mortality Public Use Data Tapes 1960-2001, US Mortality Volumes 1930-1959,National Center for Health Statistics, Centers for Disease Control and Prevention, 2004.
0
20
40
60
80
100
1930 1935 1940 1945 1950 1955 1960 1965 1970 1975 1980 1985 1990 1995 2000
Lung & bronchus
Colon & rectum
Uterus
Stomach
Breast
Ovary
Pancreas
Rate Per 100,000
Cancer Death Rates*, by Race and Ethnicity, 1997-2001
*Per 100,000, age-adjusted to the 2000 US standard population.† Hispanic is not mutually exclusive from whites, African Americans, Asian/Pacific Islanders, and American Indians.Source: Surveillance, Epidemiology, and End Results Program, 1975-2001, Division of Cancer Control andPopulation Sciences, National Cancer Institute, 2004.
245.5
151.2167.0 174.0
347.3
196.5
111.6113.4100.5
165.5
0
50
100
150
200
250
300
350
400
White African American Asian/Pacific Islander American Indian/ Alaskan Native
Hispanic†
Men Women
All sites 347.3 245.5 1.4
Prostate 70.4 28.8 2.4
Larynx 5.4 2.3 2.3
Stomach 13.3 5.8 2.3
Myeloma 9.0 4.4 2.0
Oral cavity and pharynx 7.5 3.9 1.9
Esophagus 11.7 7.4 1.6
Liver and intrahepatic bile duct 9.3 6.1 1.5
Small intestine 0.7 0.5 1.4
Colon and rectum 34.3 24.8 1.4
Lung and bronchus 104.1 76.6 1.4
Pancreas 16.0 12.0 1.3
Cancer Sites in Which African American Death Rates* Exceed White Death Rates* for Men, US, 1997-2001
*Per 100,000, age-adjusted to the 2000 US standard population.Source: Surveillance, Epidemiology, and End Results Program, 1975-2001, Division of Cancer Control and Population Sciences, National Cancer Institute, 2004.
SiteAfrican American White
Ratio of African
American/White
Cancer Sites in Which African American Death Rates* Exceed White Death Rates for Women, US, 1997-2001
*Per 100,000, age-adjusted to the 2000 US standard population.Source: Surveillance, Epidemiology, and End Results Program, 1975-2001, Division of Cancer Control and Population Sciences, National Cancer Institute, 2004.
All sites 196.5 165.5 1.2
Myeloma 6.6 2.9 2.3
Stomach 6.3 2.8 2.3
Uterine cervix 5.6 2.6 2.2
Esophagus 3.2 1.7 1.9
Larynx 0.9 0.5 1.8
Uterine corpus 6.9 3.9 1.8
Pancreas 12.8 8.9 1.4
Colon and rectum 24.5 17.1 1.4
Liver and intrahepatic bile duct 3.8 2.7 1.4
Breast 35.4 26.4 1.3
Urinary bladder 2.9 2.3 1.3
Oral cavity and pharynx 2.0 1.6 1.3
African American White Ratio of African American/WhiteSite
0
50
100
150
200
250
300
350
400
450
500
1975 1977 1979 1981 1983 1985 1987 1989 1991 1993 1995 1997 1999 2001
African American men
White men
African American women
White women
Rate Per 100,000
Cancer Death Rates* by Sex and Race, US, 1975-2001
*Age-adjusted to the 2000 US standard population.Source: Surveillance, Epidemiology, and End Results Program, 1975-2001, Division of Cancer Control and Population Sciences, National Cancer Institute, 2004.
2005 Estimated US Cancer Cases*
*Excludes basal and squamous cell skin cancers and in situ carcinomas except urinary bladder.Source: American Cancer Society, 2005.
Men710,040
Women662,870 32% Breast
12% Lung and bronchus
11% Colon and rectum
6% Uterine corpus
4% Non-Hodgkin lymphoma
4% Melanomaof skin
3% Ovary
3% Thyroid
2% Urinary bladder
2% Pancreas
21% All Other Sites
Prostate 33%
Lung and bronchus 13%
Colon and rectum 10%
Urinary bladder 7%
Melanoma of skin 5%
Non-Hodgkin4% lymphoma
Kidney 3%
Leukemia 3%
Oral Cavity 3%
Pancreas 2%
All Other Sites 17%
Cancer Incidence Rates*, All Sites Combined, All Races, 1975-2001
*Age-adjusted to the 2000 US standard population.Source: Surveillance, Epidemiology, and End Results Program, 1973-2001, Division of Cancer Control and Population Sciences, National Cancer Institute, 2004.
0
100
200
300
400
500
600
700
1975 1977 1979 1981 1983 1985 1987 1989 1991 1993 1995 1997 1999 2001
Both Sexes
Men
Women
Rate Per 100,000
Cancer Incidence Rates* for Men, US, 1975-2001
*Age-adjusted to the 2000 US standard population.Source: Surveillance, Epidemiology, and End Results Program, 1975-2001, Division of Cancer Control and Population Sciences, National Cancer Institute, 2004.
0
50
100
150
200
250
1975 1977 1979 1981 1983 1985 1987 1989 1991 1993 1995 1997 1999 2001
Prostate
Lung & bronchus
Colon & rectum
Urinary bladder
Non-Hodgkin lymphoma
Rate Per 100,000
*Age-adjusted to the 2000 US standard population.Source: Surveillance, Epidemiology, and End Results Program, 1975-2001, Division of Cancer Control andPopulation Sciences, National Cancer Institute, 2004.
Cancer Incidence Rates* for Women, US, 1975-2001
0
50
100
150
200
250
1975 1977 1979 1981 1983 1985 1987 1989 1991 1993 1995 1997 1999 2001
Breast
Lung & bronchus
Uterine corpus
Ovary
Rate Per 100,000
Colon & rectum
Cancer Incidence Rates* by Race and Ethnicity, 1997-2001
*Age-adjusted to the 2000 US standard population.†Hispanic is not mutually exclusive from whites, African Americans, Asian/Pacific Islanders, and American Indians.Source: Surveillance, Epidemiology, and End Results Program, 1975-2001, Division of Cancer Control andPopulation Sciences, National Cancer Institute, 2004.
556.5
385.9
263.2
429.8400.1
302.8
222.5
309.9
689.2
419.8
0
100
200
300
400
500
600
700
800
White African American Asian/Pacific Islander American Indian/Alaskan Native
Hispanic†
Men Women
Rate Per 100,000
Cancer Incidence Rates* by Sex and Race,All Sites, 1975-2001
*Age-adjusted to the 2000 US standard population.Source: Surveillance, Epidemiology, and End Results Program, 1975-2001, Division of Cancer Control and Population Sciences, National Cancer Institute, 2004.
0
100
200
300
400
500
600
700
800
900
1975 1977 1979 1981 1983 1985 1987 1989 1991 1993 1995 1997 1999 2001
African American men
White men
White women
African American women
Rate Per 100,000
Lifetime Probability of Developing Cancer, By Site, Men, US, 1999-2001
Source: DevCan: Probability of Developing or Dying of Cancer Software, Version 5.2 Statistical Research and Applications Branch, NCI, 2004. http://srab.cancer.gov/devcan
Site Risk
All sites 1 in 2
Prostate 1 in 6
Lung and bronchus 1 in 13
Colon and rectum 1 in 17
Urinary bladder 1 in 28
Non-Hodgkin lymphoma 1 in 46
Melanoma 1 in 53
Kidney 1 in 67
Leukemia 1 in 68
Oral Cavity 1 in 73
Stomach 1 in 81
Lifetime Probability of Developing Cancer, By Site, Women, US, 1999-2001
Source:DevCan: Probability of Developing or Dying of Cancer Software, Version 5.2 Statistical Research and Applications Branch, NCI, 2004. http://srab.cancer.gov/devcan
Site Risk
All sites 1 in 3
Breast 1 in 7
Lung & bronchus 1 in 18
Colon & rectum 1 in 18
Uterine corpus 1 in 38
Non-Hodgkin lymphoma 1 in 56
Ovary 1 in 68
Melanoma 1 in 78
Pancreas 1 in 81
Urinary bladder 1 in 88
Uterine cervix 1 in 130
Cancer Survival*(%) by Site and Race,1995-2000
*5-year relative survival rates based on cancer patients diagnosed from 1995 to 2000 and followed through 2001. Source: Surveillance, Epidemiology, and End Results Program, 1975-2001, Division of Cancer Control and Population Sciences, National Cancer Institute, 2004.
All Sites 66 55 11
Breast (female) 89 75 14
Colon 64 54 10
Esophagus 16 9 7
Leukemia 48 39 9
Non-Hodgkin lymphoma 60 51 9
Oral cavity 61 39 22
Prostate 100 96 4
Rectum 65 55 10
Urinary bladder 83 62 21
Uterine cervix 74 66 8
Uterine corpus 86 63 23
Site White DifferenceAfricanAmerican
Relative Survival* (%) during Three Time Periods,By Cancer Site
*5-year relative survival rates based on follow up of patients through 2001. †Recent changes in classification of ovarian cancer have affected 1995-2000 survival ratesSource: Surveillance, Epidemiology, and End Results Program, 1975-2001, Division of Cancer Control andPopulation Sciences, National Cancer Institute, 2004.
Site 1974-1976 1983-1985 1995-2000All sites 50 53 64
Breast (female) 75 78 88
Colon 50 58 63
Leukemia 34 41 46
Lung and bronchus 13 14 15
Melanoma of the skin 80 85 91
Non-Hodgkin lymphoma 47 54 59
Ovary 37 41 44†
Pancreas 3 3 4
Prostate 67 75 99
Rectum 49 55 64
Urinary bladder 73 78 82
1980
Cancer Incidence & Death Rates* in Children 0-14 Years, 1975-2001
0
2
4
6
8
10
12
14
16
18
1975 1985 1990 1995
Incidence
Mortality
Rate Per 100,000
2001
*Age-adjusted to the 2000 Standard population.
Source: Surveillance, Epidemiology, and End Results Program, 1975-2001, Division of Cancer Control and Population Sciences,
National Cancer Institute, 2004.
Cancer Incidence Rates* in Children 0-14 Years, By Site, 1997-2001
* Per 100,000, age-adjusted to the 2000 US standard population.ONS = Other nervous systemSource: Surveillance, Epidemiology, and End Results Program, 1975-2001, Division of Cancer Control and Population Sciences, National Cancer Institute, 2004
Site Male Female Total
All sites 15.5 14.1 14.8
Leukemia 4.8 4.2 4.5
Acute Lymphocytic 3.8 3.4 3.6
Brain/ONS 3.5 3.1 3.3
Soft tissue 1.0 1.0 1.0
Non-Hodgkin lymphoma 1.3 0.6 0.9
Kidney and renal pelvis 0.8 1.0 0.9
Bone and Joint 0.8 0.6 0.7
Hodgkin lymphoma 0.6 0.5 0.6
Cancer Death Rates* in Children 0-14 Years, By Site, 1997-2001
* Per 100,000, age-adjusted to the 2000 US standard population.ONS = Other nervous systemSource: Surveillance, Epidemiology, and End Results Program, 1975-2001, Division of Cancer Control and Population Sciences, National Cancer Institute, 2004.
Site Male Female Total
All sites 2.7 2.3 2.5
Leukemia 0.9 0.7 0.8
Acute Lymphocytic 0.4 0.3 0.4
Brain/ONS 0.7 0.7 0.7
Non-Hodgkin lymphoma 0.1 0.1 0.1
Soft tissue 0.1 0.1 0.1
Bone and Joint 0.1 0.1 0.1
Kidney and Renal pelvis 0.1 0.1 0.1
Trends in Survival, Children 0-14 Years, All Sites Combined, 1974-2000
*5-year relative survival rates, based on follow up of patients through 2001.Source: Surveillance, Epidemiology, and End Results Program, 1975-2001, Division of Cancer Control andPopulation Sciences, National Cancer Institute, 2004.
5 - Year Relative Survival Rates *Age
Year ofDiagnosis
0 - 4 Years
5 - 9 Years
10 - 14 Years
1974 -1976
1995 - 2000
1974 -1976
1995 - 2000
1974 -1976
1995 - 2000
Tobacco Use in the US, 1900-2000
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
190019051910191519201925193019351940194519501955196019651970197519801985199019952000Year
Per Capita Cigarette Consumption
0
10
20
30
40
50
60
70
80
90
100
Age-Adjusted Lung Cancer Death
Rates*
*Age-adjusted to 2000 US standard population. Source: Death rates: US Mortality Public Use Tapes, 1960-2000, US Mortality Volumes, 1930-1959, National Center for Health Statistics, Centers for Disease Control and Prevention, 2002. Cigarette consumption: US Department of Agriculture, 1900-2000.
Per capita cigarette consumption
Male lung cancer death rate
Female lung cancer death rate
Trends in Cigarette Smoking Prevalence* (%), by Gender, Adults 18 and Older, US, 1965-2002
*Redesign of survey in 1997 may affect trends.Source: National Health Interview Survey, 1965-2002, National Center for Health Statistics, Centers for Disease Control and Prevention, 2004.
0
10
20
30
40
50
60
1965 1974 1979 1983 1985 1990 1992 1994 1995 1997 1998 1999 2000 2001 2002Year
Prevalence (%)
Men
Women
Trends in per capita cigarette consumption for selected states and the average consumption across all states, 1980-2001
0
20
40
60
80
100
120
140
1980 1982 1984 1986 1988 1990 1992 1994 1996 1998 2000
Year
Per Capita Sales (# of Packs)
United States
Massachusetts
California
Data from: Orzechowski W, Walker RC. The tax burden on tobacco: historical compilation 2001: impact and opportunity, Volume 36. Arlington (VA): Orzechowski and Walker; 2001. Reprinted with permission. Source: Weir et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 2003; 95:1276-1299
Current* Cigarette Smoking Prevalence (%), by Gender and Race/Ethnicity, High School Students, US, 1991-2003
*Smoked cigarettes on one or more of the 30 days preceding the survey.Source: Youth Risk Behavior Surveillance System, 1991, 1995, 1997, 1999, 2001, 2003, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 2004.
28
35
31
13
16
27
23
11
1918
19
3230
11
14
23
40
37
12
28
33
4040
17
32
36
28
34
39 38
22
32
18
33
2726
0
10
20
30
40
50
White, non-HispanicFemale
White, non-Hispanic Male
AfricanAmerican, non-
HispanicFemale
AfricanAmerican, non-Hispanic Male
HispanicFemale
Hispanic Male
Prevalence (%)
1991 1995 1997 1999 2001 2003
Note: Data from participating states and the District of Columbia were aggregated to represent the United States.Source: Behavioral Risk Factor Surveillance System CD-ROM (1984-1995, 1996, 1998) and Public Use Data Tape (2000, 2003), National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 1997, 1999, 2000, 2001, 2004.
24.2 24.4 24.1 24.4 23.6
0
5
10
15
20
25
30
35
1994 1996 1998 2000 2003
Year
Prevalence (%)
Trends in Consumption of Five or More Recommended Vegetable and Fruit Servings for Cancer Prevention, Adults 18 and Older, US, 1994-2003
Trends in Prevalence (%) of No Leisure-Time Physical Activity, by Educational Attainment, Adults 18 and Older, US, 1992-2002
Note: Data from participating states and the District of Columbia were aggregated to represent the United States. Educational attainment is for adults 25 and older.Source: Behavioral Risk Factor Surveillance System CD-ROM (1984-1995, 1996, 1998) and Public Use Data Tape (2000, 2002), National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 1997, 1999, 2000, 2001, 2003.
05
1015202530354045505560
1992 1994 1996 1998 2000 2002Year
Prevalence (%)
Adults with less than a high school education
All adults
Trends in Prevalence (%) of High School Students Attending PE Class Daily, by Grade, US, 1991-2003
9th
10th
11th
12th
0
10
20
30
40
50
60
70
1991 1993 1995 1997 1999 2001 2003
Year
Prevalence (%)
Source: Youth Risk Behavior Surveillance System, 1991-2003, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 2004. MMWR 2004;53(36):844-847.
Trends in Overweight* Prevalence (%), Children and Adolescents, by Age Group, US, 1971-2002
*Overweight is defined as at or above the 95th percentile for body mass index by age and sex based on reference data. Source: National Health and Nutrition Examination Survey, 1971-1974, 1976-1980, 1988-1994, 1999-2002, National Center for Health Statistics, Centers for Disease Control and Prevention, 2002, 2004.
54
65
7
5
7
11 1110
16 16
0
5
10
15
20
2 to 5 years 6 to 11 years 12 to 19 years
Prevalence (%)
NHANES I (1971-74) NHANES II (1976-80) NHANES III (1988-94) NHANES 1999-2002
Trends in Obesity* Prevalence (%), By Gender, Adults Aged 20 to 74, US, 1960-2002
*Obesity is defined as a body mass index of 30 kg/m2 or greater. Source: National Health Examination Survey 1960-1962, National Health and Nutrition Examination Survey, 1971-1974, 1976-1980, 1988-1994, 1999-2002, National Center for Health Statistics, Centers for Disease Control and Prevention, 2002, 2004.
1311
161512
1715
13
17
2321
26
3028
33
0
5
10
15
20
25
30
35
40
45
Both sexes Men Women
Prevalence (%)
NHES I (1960-62) NHANES I (1971-74) NHANES II (1976-80)
NHANES III (1988-94) NHANES 1999-2002
Trends in Overweight* Prevalence (%), Adults 18 and Older, US, 1992-2003
1992 1995
1998
Less than 50% 50 to 55%
More than 55%
State did not participate in survey
*Body mass index of 25.0 kg/m2or greaterSource: Behavioral Risk Factor Surveillance System, CD-ROM (1984-1995, 1998) and Public Use Data Tape (2003), National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 1997, 2000, 2004.
2003
Screening Guidelines for the Early Detection of Breast Cancer, American Cancer Society 2003
Yearly mammograms are recommended starting at age 40 and continuing for as long as a woman is in good health.
A clinical breast exam should be part of a periodic health exam, about every three years for women in their 20s and 30s, and every year for women 40 and older.
Women should know how their breasts normally feel and report any breast changes promptly to their health care providers. Breast self-exam is an option for women starting in their 20s.
Women at increased risk (e.g., family history, genetic tendency, past breast cancer) should talk with their doctors about the benefits and limitations of starting mammography screening earlier, having additional tests (i.e., breast ultrasound and MRI), or having more frequent exams.
Mammogram Prevalence (%), by Educational Attainment and Health Insurance Status, Women 40 and Older, US, 1991-2002
* A mammogram within the past year. Note: Data from participating states and the District of Columbia were aggregated to represent the United States.Source: Behavior Risk Factor Surveillance System CD-ROM (1984-1995, 1996-1997, 1998, 1999) and Public Use Data Tape (2000, 2002), National Centers for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 1997, 1999, 2000, 2000, 2001, 2003.
0
10
20
30
40
50
60
70
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2002Year
Prevalence (%)
Women with less than a high school education
Women with no health insurance
All women 40 and older
Screening Guidelines for the Early Detection of Cervical Cancer, American Cancer Society 2003
Screening should begin approximately three years after a women begins having vaginal intercourse, but no later than 21 years of age.
Screening should be done every year with regular Pap tests or every two years using liquid-based tests.
At or after age 30, women who have had three normal test results in a row may get screened every 2-3 years. However, doctors may suggest a woman get screened more if she has certain risk factors, such as HIV infection or a weakened immune system.
Women 70 and older who have had three or more consecutive Pap tests in the last ten years may choose to stop cervical cancer screening.
Screening after a total hysterectomy (with removal of the cervix) is not necessary unless the surgery was done as a treatment for cervical cancer.
Trends in Recent* Pap Test Prevalence (%), by Educational Attainment and Health Insurance Status, Women 18 and Older, US, 1992-2002
* A Pap test within the past three years. Note: Data from participating states and the District of Columbia were aggregated to represent the United States. Educational attainment is for women 25 and older.Source: Behavior Risk Factor Surveillance System CD-ROM (1984-1995, 1996-1997, 1998, 1999) and Public Use Data Tape (2000, 2002), National Center for Chronic Disease Prevention and Health Promotion, Center for Disease Control and Prevention, 1997, 1999, 2000, 2000, 2001, 2003.
0
20
40
60
80
100
1992 1993 1994 1995 1996 1997 1998 1999 2000 2002Year
Prevalence (%)
Women with no health insurance
Women with less than a high school education
All women 18 and older
Screening Guidelines for the Early Detection of Colorectal Cancer, American Cancer Society 2003
Beginning at age 50, men and women should follow one of the following examination schedules:
A fecal occult blood test (FOBT) every year
A flexible sigmoidoscopy (FSIG) every five years
Annual fecal occult blood test and flexible sigmoidoscopy every five years*
A double-contrast barium enema every five years
A colonoscopy every ten years
*Combined testing is preferred over either annual FOBT, or FSIG every 5 years alone.
People who are at moderate or high risk for colorectal cancer should talk with a doctor about a different testing schedule
19.8
16.2
8.2
20.8
16.2
9.4
18.3
12.0
21.8
15.9
9.0
23.9
0
5
10
15
20
25
30
Total Less than a high schooleducation
No health insurance
Prevalence (%)
1997 1999 2001 2002
Trends in Recent* Fecal Occult Blood Test Prevalence (%), by Educational Attainment and Health Insurance Status, Adults 50 Years and Older, US, 1997-2002
*A fecal occult blood test within the past year. Note: Data from participating states and the District of Columbia were aggregated to represent the United States. Source: Behavioral Risk Factor Surveillance System CD-ROM (1996-1997, 1999) and Public Use Data Tape (2001, 2002), National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention and Prevention, 1999, 2000, 2002, 2003.
30.527.7
16.5
33.7
29.2
15.6
38.9
31.8
17.5
40.5
32.5
18.5
0
5
10
15
20
25
30
35
40
45
Total Less than a high schooleducation
No health insurance
Prevalence (%)
1997 1999 2001 2002
Trends in Recent* Flexible Sigmoidoscopy Prevalence (%), by Educational Attainment and Health Insurance Status, Adults 50 Years and Older, US, 1997-2002
*A flexible sigmoidoscopy or colonoscopy within the past five years. Note: Data from participating states and the District of Columbia were aggregated to represent the United States. Source: Behavioral Risk Factor Surveillance System CD-ROM (1996-1997, 1999) and Public Use Data Tape (2001, 2002), National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention and Prevention, 1999, 2000, 2002, 2003.
Screening Guidelines for the Early Detection of Prostate Cancer, American Cancer Society 2003
The prostate-specific antigen (PSA) test and the digital rectal examination (DRE) should be offered annually, beginning at age 50, to men who have a life expectancy of at least 10 years.
Men at high risk (African-American men and men with a strong family history of one or more first-degree relatives diagnosed with prostate cancer at an early age) should begin testing at age 45.
For men at average risk and high risk, information should be provided about what is known and what is uncertain about the benefits and limitations of early detection and treatment of prostate cancer so that they can make an informed decision about testing.
58.3
45.7
30.1
42.0
28.4
55.5
0
10
20
30
40
50
60
70
Total Less than a high school
education
No health insurance
Prevalence (%)
2001 2002
Recent* Prostate-Specific Antigen (PSA) Test Prevalence (%), by Educational Attainment and Health Insurance Status, Men 50 Years and Older, US, 2001-2002
*A prostate-specific antigen (PSA) test within the past year. Note: Data from participating states and the District of Columbia were aggregated to represent the United States. Source: Behavioral Risk Factor Surveillance System Public Use Data Tape (2001, 2002), National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 2002, 2003.
56.5
44.0
28.8
52.9
41.9
26.4
0
10
20
30
40
50
60
Total Less than a high school
education
No health insurance
Prevalence (%)
2001 2002
Recent* Digital Rectal Examination (DRE) Prevalence (%), by Educational Attainment and Health Insurance Status, Men 50 Years and Older, US, 2001-2002
*A digital rectal examination (DRE) within the past year. Note: Data from participating states and the District of Columbia were aggregated to represent the United States. Source: Behavioral Risk Factor Surveillance System Public Use Data Tape (2001, 2002), National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 2002, 2003.
Sunburn* Prevalence (%) in the Past Year, Adults 18 and Older, US, 1999
44.1
35.3
27.4
23.5
13.3
18.0
11.0
5.3 5.1
22.0
0
5
10
15
20
25
30
35
40
45
50
Male Female
Age-Adjusted Prevalence (%)
White non-Hispanic
AmericanIndian/AlaskanNative
Other
Asian/ PacificIslander
Black non-Hispanic
*Reddening of any part of the skin (regardless of size) for more than 12 hours. Source: Saraiya et al. Am J Prev Med 2002;23(2). Note: The overall prevalence of sunburn among adult males is 39.7% and among females is 28.8%. Behavioral Risk Factor Surveillance System CD-ROM, 1999. National Center for Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 2000.
Sunburn* Prevalence (%) During the Past Summer, Youth 11-18, US, 1998
70.874.1
85.5
77.2
64.1
58.4
36.7
70.874.1
55.2
0
10
20
30
40
50
60
70
80
90
Male Female White Black Other
American IndianAsian/Pacific Islander Low Sun Sensitivity
Medium Sun SensitivityHigh Sun Sensitivity
Prevalence (%)
*Any reddening of the skin that lasts for at least 12 hours from either exposure to the sun or from a tanning booth or sunlamp. Note: Prevalence estimates for racial/ethnic categories other than white may not be stable due to small sample sizes and have wide confidence intervals. Source: Davis et al. Pediatrics 2002;110(1).
Thank you